Hypopharyngeal malignant tumor generally refers to hypopharyngeal cancer, which is a more serious disease, and the prognosis is usually worse if patients do not receive timely treatment. Hypopharyngeal cancer is a relatively rare malignant tumor in clinic, the specific cause of which is not clear at present, and it is considered to be related to long-term smoking, alcoholism, long-term lack of vitamin C, iron and other nutrients and other factors. The disease is more serious, firstly, patients often have symptoms such as pain in the throat, difficulty in swallowing, hoarseness, neck lumps, etc., which have a greater impact on patients’ daily life. Secondly, as the disease belongs to malignant tumor, the tumor volume will increase continuously and rapidly, thus forming pressure on the tissues and organs around the hypopharynx, leading to symptoms such as respiratory obstruction and dyspnea, etc. If the cancer cells spread and metastasize, it will also lead to the occurrence of secondary malignant tumors in the throat and lungs, etc. Meanwhile, patients with stage I and stage II cancer may suffer from pain in the throat, hoarse voice, difficulty in swallowing, etc., which has a greater impact on their daily life. Meanwhile, the 5-year survival rate of patients with stage I and stage II hypopharyngeal cancer is between 40% and 50% after active treatment, whereas if patients do not receive timely treatment, the disease develops to advanced stage, or the treatment is purely radiotherapy or surgical treatment, the prognosis is usually poorer, and the 5-year survival rate is lower, which may only be between 10% and 20%. It is recommended that patients diagnosed with hypopharyngeal cancer should seek medical treatment as early as possible to improve clinical symptoms and prolong the survival cycle to avoid delaying the disease.